Ressources

Plasma de convalescents ou immunoglobuline hyperimmune chez les personnes atteintes de la COVID‐19: une revue systématique dynamique

Product: — Cochrane Library

Drug Interventions Immune System Treatments Vaccines & Immunity

www.cochranelibrary.com Dernière mise à jour: mai 20, 2021

Also available in English

Remdesivir for Hospitalized Patients with COVID-19

Product: — Science Table

Drug Interventions Treatments

covid19-sciencetable.ca Dernière mise à jour: mai 6, 2021

Clinical Practice Guidelines Webinar: Tocilizumab

Product: — Science Table

Drug Interventions Healthcare Workers Models Treatments

covid19-sciencetable.ca Dernière mise à jour: avril 26, 2021

La chloroquine ou l’hydroxychloroquine dans la prévention ou le traitement de la COVID-19

Product: — Canadian Agency for Drugs and Technologies in Health

Drug Interventions Treatments

covid.cadth.ca Dernière mise à jour: avril 26, 2021

Also available in English

Essais en cours sur des médicaments visant à prévenir ou à traiter la COVID-19

Product: — Canadian Agency for Drugs and Technologies in Health

Drug Interventions Treatments

covid.cadth.ca Dernière mise à jour: avril 22, 2021

Also available in English

Strategies to Manage Tocilizumab Supply During the COVID‑19 Pandemic

Product: — Science Table

Drug Interventions Future Planning Treatments

covid19-sciencetable.ca Dernière mise à jour: avril 19, 2021

Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19

Product: — Science Table

Drug Interventions Treatments

covid19-sciencetable.ca Dernière mise à jour: avril 6, 2021

Indoor Versus Outdoor Transmission of COVID-19

Product: — Evidence Synthesis Network

About Coronavirus Transmission

esnetwork.ca Dernière mise à jour: mars 26, 2021

Le tocilizumab et le sarilumab : examen et évaluation des données probantes

Product: — Canadian Agency for Drugs and Technologies in Health

Drug Interventions Treatments

covid.cadth.ca Dernière mise à jour: mars 25, 2021

Also available in English

L’association casirivimab-imdévimab et la COVID‑19 : examen et évaluation des données probantes

Product: — Canadian Agency for Drugs and Technologies in Health

Drug Interventions Treatments

covid.cadth.ca Dernière mise à jour: mars 25, 2021

Also available in English